This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Massachusetts Institute of Technology. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Guozhu Xie: Innovator in Cancer Immunotherapy
Introduction
Guozhu Xie is a prominent inventor based in Cambridge, MA, specializing in the field of cancer immunotherapy. His innovative work focuses on developing methods and compositions that target specific cancer mutations, particularly the NPM1c-positive cancer.
Latest Patents
Guozhu Xie holds a patent for "Compositions and methods for immunotherapy of NPM1c-positive cancer." This patent discloses compounds such as antibodies and bispecific molecules that bind to a neoepitope of mutant nucleophosmin (NPM1c). These compounds are designed to interact with class I major histocompatibility complex (MHC class I) proteins, facilitating their use in treating or alleviating symptoms of cancer.
Career Highlights
Guozhu Xie is affiliated with the Massachusetts Institute of Technology, where he contributes to groundbreaking research in immunotherapy. His work has significant implications for the treatment of cancers associated with specific genetic mutations.
Collaborations
Guozhu Xie collaborates with Jianzhu Chen, a fellow researcher, to advance their shared goals in cancer research and therapy development.
Conclusion
Guozhu Xie's contributions to cancer immunotherapy through his innovative patent and collaboration with esteemed colleagues highlight his commitment to improving cancer treatment options. His work continues to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile